✨ Health Notices
14 JANUARY NEW ZEALAND GAZETTE 57
executed on the 21st day of December 1998. Copies of the
supplementary integration agreements are available for
inspection without charge by any member of the public
at the district office of the Ministry of Education,
39–45 College Hill, Ponsonby, Auckland.
Dated at Wellington this 21st day of December 1998.
KATHY PHILLIPS. Senior Manager, National Operations.
go183
Health
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Factor IX 500IU and water for injection 10 mL, as diluent | Injection, powder (vial) with diluent (ampoule) | CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia; Diluent: Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia | MonoFix-VF |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 22nd day of December 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go268
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Loperamide hydrochloride 2 mg | Tablet | Apotex Inc., Weston, Ontario, Canada | Apo-Loperamide |
| Bifonazole 1% w/w | Cream, topical | Bayer AG., Leverkusen, Germany and Bayer Australia Limited, Health Care Operations Centre, Mulgrave, Victoria, Australia | Canesten Once Daily Bifonazole |
| Desonide 0.05% w/w | Ointment, topical | Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France | Desowen |
| Desonide 0.05% w/w | Cream, topical | Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France | Desowen |
| Desonide 0.05% w/w | Lotion, skin | Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France | Desowen |
| Salicylic acid 27% w/w | Gel, topical | Stiefel Laboratories (Ireland) Limited, Sligo, Ireland | Duofilm |
| Codeine phosphate (anhydrous) 12.8 mg, ibuprofen 200 mg | Tablet | The Boots Company Plc., Beeston, Nottingham, United Kingdom | Nurofen Plus |
| Camphor 1.24% w/w, menthol 5.71% w/w, methyl salicylate 6.29% w/w | Transdermal patch | Hisamitsu Pharmaceutical Co Inc., Tosu, Saga, Japan | Salonpas |
| Betahistine hydrochloride 4 mg, 8 mg, 16 mg | Tablets | Solvay Duphar BV., Olst, The Netherlands | Serc |
| Carmellose sodium 2.5 mg/mL | Drops, eye, solution | Ciba Vision Sterile Manufacturing, Mississauga, Ontario, Canada | Thera Tears |
Dated this 11th day of January 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go344
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 1
NZLII —
NZ Gazette 1999, No 1
✨ LLM interpretation of page content
🏥 Provisional Consent to Distribution of New Medicine
🏥 Health & Social Welfare22 December 1998
Medicines Act 1981, Provisional Consent, New Medicine, Factor IX, MonoFix-VF
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare11 January 1999
Medicines Act 1981, New Medicines, Loperamide, Bifonazole, Desonide, Salicylic Acid, Codeine Phosphate, Ibuprofen, Camphor, Menthol, Methyl Salicylate, Betahistine Hydrochloride, Carmellose Sodium
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines Act 1981, Changed Medicines, Section 24(5)